News Pfizer’s New Oral Pill for Obesity Drug Market Pfizer has decided on the pill it plans to use to compete in the new obesity-drug market pioneered by major pharmaceutical companies Eli ... By Artur FernandoJune 30, 20230
News Pfizer’s Danuglipron for Obesity and Type 2 Diabetes Pfizer Inc. has announced plans to focus on developing its oral candidate danuglipron as a treatment for obesity and type 2 diabetes. This ... By Artur FernandoJune 28, 20230
BlackRock is reviewing TechBerry and negotiating a possible full or partial acquisition of the company June 20, 2024